article thumbnail

Globus Medical and NuVasive to Combine in All-Stock Transaction to Create Innovative Global Musculoskeletal Company Focused on Patient Care

Legacy MEDSearch

Globus Medical (NYSE: GMED), a leading musculoskeletal solutions company, and NUVASIVE (NASDAQ: NUVA), the leader in spine technology innovation, today announced they have entered into a definitive agreement to combine in an all-stock transaction. Additional information can be accessed at www.globusmedical.com.

Medical 98
article thumbnail

Top 4 Surgical Instrument Companies in the USA

Medico Reach

J&J has a long history of leading the way in the development of surgical instruments and surgical equipment, dating back over 130 years. Boston Scientific is among the world’s leading surgical equipment manufacturers, treating approximately 22 million patients every year. Boston Scientific.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Drug developers look at innovative mechanisms to tackle dry eye syndrome

Pharmaceutical Technology

Dry eye syndrome (DES) is an indication whose mainstay treatment has been dominated by Allergan’s Restasis (cyclosporine ophthalmic emulsion 0.05%) ever since its launch in 2003 in the US. NOV-03 is also likely to be well-received by physicians and patients due to its favorable clinical and tolerability profile.

article thumbnail

FINN Partners Further Expands into Asia with Addition of SPAG

PM360

FINN Partners , an independent marketing and communications agency, is expanding its global footprint even further with the addition of SPAG , a leading, Asia-headquartered, health-sector communications and marketing firm with offices in Bangalore, Delhi, Indonesia, Malaysia, Mumbai, the Philippines, and Singapore.

article thumbnail

Amarin Makes Moves towards Global Expansion of Vazkepa

Pharmaceutical Technology

AstraZeneca ’s cholesterol drug Crestor (rosuvastatin) was approved in 2003 in the US but only approved in Germany in 2008. The World Health Organization (WHO) reports that cardiovascular disease is the major leading cause of death, with 17.9 The company now faces a highly competitive generics market for its lead drug.

article thumbnail

The 4 Types of Medtech Innovation  

Cesare Ferrari

Thanks to its success, two researchers, Lauterbur and Mansfield , were awarded the 2003 Nobel Prize in Medicine, and millions of patients have their lives saved or significantly improved. Poor identification of the type of innovation can lead to a poor understanding of its characteristics and full potential.

article thumbnail

Developing new treatment regimens for HIV

European Pharmaceutical Review

Self-stigma is also prevalent and hinders individuals from getting tested, starting pre‑exposure prophylaxis (PrEP) (if they’re HIV negative), seeking the lifesaving treatments they need (if they’re HIV positive), and can lead to isolation and depression. 3 But that paradigm is rapidly changing. References 1. World Health Organization.